$1.64 Billion is the total value of Redmile Group, LLC's 64 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 46.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARRY | Buy | ARRAY BIOPHARMA INC | $134,705,000 | +18.0% | 16,093,786 | +26.1% | 8.20% | +10.7% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $121,282,000 | +49.5% | 12,043,932 | +5.9% | 7.38% | +40.3% |
| PEN | Sell | PENUMBRA INC | $81,734,000 | -5.3% | 931,444 | -10.0% | 4.98% | -11.2% |
| PBYI | Sell | PUMA BIOTECHNOLOGY INC | $75,204,000 | +17.2% | 860,456 | -50.1% | 4.58% | +9.9% |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $71,570,000 | +15.6% | 764,389 | -21.4% | 4.36% | +8.4% |
| JUNO | New | JUNO THERAPEUTICS INC | $66,344,000 | – | 2,219,616 | +100.0% | 4.04% | – |
| MOH | Sell | MOLINA HEALTHCARE INC | $57,321,000 | +9.3% | 828,574 | -27.9% | 3.49% | +2.5% |
| INCR | Buy | INC RESH HLDGS INCcl a | $49,223,000 | +69.4% | 841,418 | +32.8% | 3.00% | +58.9% |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $44,605,000 | +10.9% | 444,936 | +33.8% | 2.72% | +4.0% |
| ANTM | Buy | ANTHEM INC | $43,625,000 | +50.5% | 231,886 | +32.3% | 2.66% | +41.1% |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $41,374,000 | +18.4% | 2,224,407 | +75.0% | 2.52% | +11.0% |
| ATRA | Sell | ATARA BIOTHERAPEUTICS INC | $38,277,000 | -31.9% | 2,734,044 | -0.0% | 2.33% | -36.1% |
| IMGN | Buy | IMMUNOGEN INC | $37,063,000 | +140.3% | 5,212,736 | +30.8% | 2.26% | +125.4% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $36,263,000 | +16.8% | 2,155,949 | +7.5% | 2.21% | +9.5% |
| AGIO | Sell | AGIOS PHARMACEUTICALS INC | $35,046,000 | -33.5% | 681,165 | -24.5% | 2.13% | -37.6% |
| SGEN | Sell | SEATTLE GENETICS INC | $34,414,000 | -21.4% | 665,139 | -4.5% | 2.10% | -26.3% |
| RGNX | Buy | REGENXBIO INC | $33,944,000 | +38.6% | 1,718,671 | +35.4% | 2.07% | +29.9% |
| CNC | New | CENTENE CORP DEL | $31,808,000 | – | 398,200 | +100.0% | 1.94% | – |
| ELGX | Buy | ENDOLOGIX INC | $30,950,000 | +57.3% | 6,368,299 | +134.4% | 1.88% | +47.5% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $30,353,000 | +1.7% | 1,094,983 | -8.8% | 1.85% | -4.6% |
| BOLD | Buy | AUDENTES THERAPEUTICS INC | $27,922,000 | +99.6% | 1,459,616 | +77.8% | 1.70% | +87.2% |
| PRTA | Sell | PROTHENA CORP PLC | $27,585,000 | -41.8% | 509,698 | -40.0% | 1.68% | -45.4% |
| EW | New | EDWARDS LIFESCIENCES CORP | $25,776,000 | – | 218,000 | +100.0% | 1.57% | – |
| Buy | ARRAY BIOPHARMA INCnote 3.000% 6/0 | $25,656,000 | +101.0% | 19,000,000 | +111.1% | 1.56% | +88.6% | |
| ALDR | Buy | ALDER BIOPHARMACEUTICALS INC | $25,463,000 | -35.9% | 2,223,811 | +16.4% | 1.55% | -39.9% |
| XNCR | Sell | XENCOR INC | $25,068,000 | -34.2% | 1,187,494 | -25.4% | 1.53% | -38.3% |
| SPNC | Buy | SPECTRANETICS CORP | $24,376,000 | +50.2% | 634,802 | +13.9% | 1.48% | +40.9% |
| EHTH | Buy | EHEALTH INC | $22,999,000 | +60.3% | 1,223,334 | +2.7% | 1.40% | +50.4% |
| CMRX | Sell | CHIMERIX INC | $22,931,000 | -16.9% | 4,207,575 | -2.7% | 1.40% | -22.1% |
| ICUI | Sell | ICU MED INC | $22,857,000 | -6.8% | 132,505 | -17.5% | 1.39% | -12.6% |
| LJPC | Buy | LA JOLLA PHARMACEUTICAL CO | $21,234,000 | +17.7% | 713,280 | +18.0% | 1.29% | +10.4% |
| IRTC | New | IRHYTHM TECHNOLOGIES INC | $20,240,000 | – | 476,341 | +100.0% | 1.23% | – |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $18,623,000 | +16.4% | 367,537 | -8.1% | 1.13% | +9.2% |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $18,610,000 | – | 144,408 | +100.0% | 1.13% | – |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $17,266,000 | -49.9% | 631,283 | -32.4% | 1.05% | -53.0% |
| Sell | NEURODERM LTD | $16,597,000 | -32.4% | 555,096 | -39.9% | 1.01% | -36.6% | |
| NXTM | New | NXSTAGE MEDICAL INC | $16,480,000 | – | 657,356 | +100.0% | 1.00% | – |
| JNCE | Buy | JOUNCE THERAPEUTICS INC | $15,971,000 | -29.1% | 1,138,370 | +2.2% | 0.97% | -33.5% |
| SYRS | Buy | SYROS PHARMACEUTICALS INC | $15,660,000 | +3.2% | 973,260 | +2.2% | 0.95% | -3.2% |
| NSTG | Sell | NANOSTRING TECHNOLOGIES INC | $14,337,000 | -22.8% | 866,819 | -7.2% | 0.87% | -27.6% |
| CLVS | New | CLOVIS ONCOLOGY INCcall | $14,232,000 | – | 152,000 | +100.0% | 0.87% | – |
| CASC | Sell | CASCADIAN THERAPEUTICS INC | $13,879,000 | -17.7% | 3,735,994 | -8.3% | 0.84% | -22.8% |
| LIVN | New | LIVANOVA PLC | $12,978,000 | – | 212,028 | +100.0% | 0.79% | – |
| MODN | Buy | MODEL N INC | $11,416,000 | +32.9% | 858,314 | +4.4% | 0.70% | +24.6% |
| CTMX | Buy | CYTOMX THERAPEUTICS INC | $10,825,000 | -8.1% | 698,392 | +2.4% | 0.66% | -13.7% |
| New | PUMA BIOTECHNOLOGY INCcall | $8,871,000 | – | 101,500 | +100.0% | 0.54% | – | |
| PRQR | Buy | PROQR THRAPEUTICS N V | $8,301,000 | +6.9% | 1,596,275 | +2.8% | 0.50% | +0.2% |
| NVTA | INVITAE CORP | $7,765,000 | -13.6% | 812,240 | 0.0% | 0.47% | -18.9% | |
| GLYC | New | GLYCOMIMETICS INC | $6,692,000 | – | 599,620 | +100.0% | 0.41% | – |
| MEDP | New | MEDPACE HLDGS INC | $6,526,000 | – | 225,040 | +100.0% | 0.40% | – |
| CTLT | Sell | CATALENT INC | $5,123,000 | -71.0% | 145,963 | -76.6% | 0.31% | -72.8% |
| FATE | FATE THERAPEUTICS INC | $4,598,000 | -28.8% | 1,419,058 | 0.0% | 0.28% | -33.2% | |
| OVID | New | OVID THERAPEUTICS INC | $4,237,000 | – | 448,781 | +100.0% | 0.26% | – |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $2,564,000 | -5.2% | 94,560 | +4.3% | 0.16% | -11.4% |
| AUPH | Buy | AURINIA PHARMACEUTICALS INC | $2,037,000 | +98.0% | 332,310 | +137.0% | 0.12% | +85.1% |
| UNH | UNITEDHEALTH GROUP INC | $337,000 | +13.1% | 1,820 | 0.0% | 0.02% | +10.5% | |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $305,000 | -98.9% | 6,640 | -98.9% | 0.02% | -98.9% |
| AGN | New | ALLERGAN PLC | $292,000 | – | 1,200 | +100.0% | 0.02% | – |
| NKTR | New | NEKTAR THERAPEUTICS | $285,000 | – | 14,580 | +100.0% | 0.02% | – |
| AMED | Sell | AMEDISYS INC | $211,000 | -14.6% | 3,356 | -30.5% | 0.01% | -18.8% |
| INSM | New | INSMED INC | $212,000 | – | 12,380 | +100.0% | 0.01% | – |
| BKD | New | BROOKDALE SR LIVING INC | $178,000 | – | 12,110 | +100.0% | 0.01% | – |
| CSLT | CASTLIGHT HEALTH INCcl b | $42,000 | +13.5% | 10,229 | 0.0% | 0.00% | +50.0% | |
| ADVM | ADVERUM BIOTECHNOLOGIES INC | $56,000 | -6.7% | 22,236 | 0.0% | 0.00% | -25.0% | |
| RARX | Exit | RA PHARMACEUTICALS INC | $0 | – | -110,769 | -100.0% | -0.15% | – |
| AVXS | Exit | AVEXIS INC | $0 | – | -45,349 | -100.0% | -0.22% | – |
| SGRY | Exit | SURGERY PARTNERS INC | $0 | – | -303,500 | -100.0% | -0.38% | – |
| DVAX | Exit | DYNAVAX TECHNOLOGIES CORP | $0 | – | -1,019,491 | -100.0% | -0.39% | – |
| CRL | Exit | CHARLES RIV LABS INTL INC | $0 | – | -121,307 | -100.0% | -0.71% | – |
| MCK | Exit | MCKESSON CORP | $0 | – | -78,300 | -100.0% | -0.75% | – |
| PRXL | Exit | PAREXEL INTL CORP | $0 | – | -260,231 | -100.0% | -1.07% | – |
| ESRX | Exit | EXPRESS SCRIPTS HLDG CO | $0 | – | -293,807 | -100.0% | -1.26% | – |
| DPLO | Exit | DIPLOMAT PHARMACY INC | $0 | – | -1,254,342 | -100.0% | -1.30% | – |
| PTHN | Exit | PATHEON N V | $0 | – | -826,843 | -100.0% | -1.41% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -3,380,846 | -100.0% | -1.42% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -307,723 | -100.0% | -2.67% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.